27th May 2021 First-in-Human Safety and Mechanism of Action (MOA) Analyses of Repeatedly Dosed In Vivo Gene Delivery for Directed Human Type III Collagen (COL3) Expression in Aesthetics
26th May 2021 In Vitro and In Vivo Pharmacology of KB301, an HSV-1-Based Gene Therapy, for the Treatment of Superficial Skin Depressions